BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 38065702)

  • 1. A Fully Automated Artificial Intelligence System to Assist Pathologists' Diagnosis to Predict Histologically High-grade Urothelial Carcinoma from Digitized Urine Cytology Slides Using Deep Learning.
    Tsuji K; Kaneko M; Harada Y; Fujihara A; Ueno K; Nakanishi M; Konishi E; Takamatsu T; Horiguchi G; Teramukai S; Ito-Ihara T; Ukimura O
    Eur Urol Oncol; 2024 Apr; 7(2):258-265. PubMed ID: 38065702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of an artificial intelligence algorithm for reporting urine cytopathology.
    Sanghvi AB; Allen EZ; Callenberg KM; Pantanowitz L
    Cancer Cytopathol; 2019 Oct; 127(10):658-666. PubMed ID: 31412169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Paris System for reporting urinary cytology improves the negative predictive value of high-grade urothelial carcinoma.
    Yamasaki M; Taoka R; Katakura K; Matsunaga T; Kani N; Honda T; Harada S; Tohi Y; Matsuoka Y; Kato T; Okazoe H; Tsunemori H; Ueda N; Haba R; Sugimoto M
    BMC Urol; 2022 Apr; 22(1):51. PubMed ID: 35382830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical Category of the Johns Hopkins Template Has Higher Risk of Malignancy than the Paris System but the Paris System Is More Applicable for Suspicious Category.
    Celik B; Kavas G
    Acta Cytol; 2023; 67(4):425-433. PubMed ID: 36731438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reclassification of urinary cytology regarding The Paris System for Reporting Urinary Cytology with cytohistological correlation demonstrates high sensitivity for high-grade urothelial carcinoma.
    Anbardar MH; Monjazeb R
    Diagn Cytopathol; 2020 May; 48(5):446-452. PubMed ID: 31976626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Implementation and Diagnostic Accuracy of the Paris Classification for Reporting Urinary Cytology in Voided Urine Specimens: A Cyto-Histological Correlation Study in a Cancer Center.
    Lobo J; Lobo C; Leça L; Rodrigues Â; Henrique R; Monteiro P
    Pathobiology; 2023; 90(4):233-240. PubMed ID: 36574757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An institutional experience with The Paris System: A paradigm shift from ambiguous terminology to more objective criteria for reporting urine cytology.
    Roy M; Kaushal S; Jain D; Seth A; Iyer VK; Mathur SR
    Cytopathology; 2017 Dec; 28(6):509-515. PubMed ID: 28833848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative cytomorphological comparison of SurePath and ThinPrep liquid-based cytology using high-grade urothelial carcinoma cells.
    Okuda C; Kyotake A; Nakamura A; Itoh T; Kamoshida S; Ohsaki H
    Cytopathology; 2021 Sep; 32(5):654-659. PubMed ID: 34033150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An artificial intelligence-powered PD-L1 combined positive score (CPS) analyser in urothelial carcinoma alleviating interobserver and intersite variability.
    Lee KS; Choi E; Cho SI; Park S; Ryu J; Puche AV; Ma M; Park J; Jung W; Ro J; Kim S; Park G; Song S; Ock CY; Choe G; Park JH
    Histopathology; 2024 Jul; 85(1):81-91. PubMed ID: 38477366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of The Paris System for Reporting Urine Cytology improves diagnostic accuracy of selective upper urinary tract cytology.
    Miyai K; Nakayama M; Minabe S; Ogata S; Ito K; Matsukuma S
    Cancer Cytopathol; 2024 Apr; 132(4):242-249. PubMed ID: 38294961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urine cell image recognition using a deep-learning model for an automated slide evaluation system.
    Kaneko M; Tsuji K; Masuda K; Ueno K; Henmi K; Nakagawa S; Fujita R; Suzuki K; Inoue Y; Teramukai S; Konishi E; Takamatsu T; Ukimura O
    BJU Int; 2022 Aug; 130(2):235-243. PubMed ID: 34143569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of an artificial intelligence algorithm for assisting the Paris System in reporting urinary cytology: A pilot study.
    Ou YC; Tsao TY; Chang MC; Lin YS; Yang WL; Hang JF; Li CB; Lee CM; Yeh CH; Liu TJ
    Cancer Cytopathol; 2022 Nov; 130(11):872-880. PubMed ID: 35727052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combination cytology/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence?
    Pierconti F; Martini M; Fiorentino V; Cenci T; Capodimonti S; Straccia P; Sacco E; Pugliese D; Cindolo L; Larocca LM; Bassi PF
    Urol Oncol; 2021 Feb; 39(2):131.e17-131.e21. PubMed ID: 32773233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are we on track for diagnosing high-grade urothelial carcinoma with a minimum quantity of five malignant cells in lower tract specimens? Critical analysis of The Paris System Quantitation Criteria.
    Folarin OS; Siddiqui MT
    Cancer Cytopathol; 2023 Nov; 131(11):708-715. PubMed ID: 37572083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the Paris Reporting System for Urine Cytology: The Three-Year Experience of a Single Tertiary Care Institute in Thailand.
    Phruttinarakorn B; Plumworasawat S; Kayankarnnavee J; Lualon J; Pongtippan A
    Acta Cytol; 2022; 66(2):134-141. PubMed ID: 34999581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of the Paris System in Urine Cytology for Improved Screening of High-Grade Urothelial Carcinoma in Bahrain.
    Mahmoud Daoud R; Ali AH; Salim Fredericks S; Daoud S; Gomaa HR; AlHashimi FS
    Cureus; 2024 Mar; 16(3):e57189. PubMed ID: 38681345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementing The Paris System for Reporting Urinary Cytology results in a decrease in the rate of the "atypical" category and an increase in its prediction of subsequent high-grade urothelial carcinoma.
    Wang Y; Auger M; Kanber Y; Caglar D; Brimo F
    Cancer Cytopathol; 2018 Mar; 126(3):207-214. PubMed ID: 29278461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Paris System for urine cytology in upper tract urothelial specimens: A comparative analysis with biopsy and surgical resection.
    Zheng X; Si Q; Du D; Harshan M; Zhang Z; Haines K; Shi W; Chhieng DC
    Cytopathology; 2018 Apr; 29(2):184-188. PubMed ID: 29251368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of a comprehensive, urothelial carcinoma-specific next-generation sequencing panel in urine cytology and bladder tumor specimens.
    Sun T; Hutchinson L; Tomaszewicz K; Caporelli ML; Meng X; McCauley K; Fischer AH; Cosar EF; Cornejo KM
    Cancer Cytopathol; 2021 Jul; 129(7):537-547. PubMed ID: 33539671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the Paris system for reporting urinary cytology with histologic follow-up.
    Rohra P; Ocampo Gonzalez FA; Yan L; Mir F; Furlan K; Basu S; Barua A; Cheng L; Park JW
    Diagn Cytopathol; 2021 Jun; 49(6):691-699. PubMed ID: 33600080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.